+11.5%
CLF vs GSK
+26.4%
-14.9%
-51.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.7% | -2.7% | +1.0% | -1.3% |
| 7D | +6.5% | -4.2% | +10.7% | +7.2% |
| 30D | +0.2% | -7.5% | +7.8% | +1.5% |
| 3M | -3.1% | -3.3% | +0.2% | -2.6% |
| 6M | +25.0% | -9.3% | +34.4% | +26.7% |
| YTD | -7.5% | +1.6% | -9.1% | -4.3% |
| 1Y | +11.5% | +25.5% | -14.0% | +19.6% |
| All | +11.5% | +26.4% | -14.9% | +19.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling